|View printer-friendly version|
|Array BioPharma to Present at the C.E. Unterberg, Towbin Life Sciences Conference|
BOULDER, Colo., Oct 23, 2006 (BUSINESS WIRE) -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Robert E. Conway, will speak at the C.E. Unterberg, Towbin Life Sciences Conference on October 30 in New York City. The public is welcome to participate in the conference through an audio webcast on the Array BioPharma website.
Event: C.E. Unterberg, Towbin Life Sciences Conference Presenter: Robert E. Conway, Chief Executive Officer, Array BioPharma Date: Monday, October 30, 2006 Time: 9:00 a.m. Eastern Time Location: The Palace Hotel, New York City Audio Webcast: www.arraybiopharma.com
About Array BioPharma:
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat life threatening and debilitating diseases. Our proprietary drug development pipeline is focused on the treatment of cancer and inflammatory disease and includes clinical candidates that are designed to regulate therapeutically important targets. In addition, leading pharmaceutical and biotechnology companies collaborate with Array to discover and develop drug candidates across a broad range of therapeutic areas. For more information on Array, please go to www.arraybiopharma.com.
SOURCE: Array BioPharma Inc.
Array BioPharma Inc. Tricia Haugeto, 303-386-1193 firstname.lastname@example.org